Literature DB >> 3464435

Cefmenoxime kinetics during continuous ambulatory peritoneal dialysis.

D A Sica, R E Polk, T M Kerkering, P Patterson, J Baggett.   

Abstract

The kinetics of the aminothiazolyliminomethoxy cephalosporin, cefmenoxime, were determined after a 30 min intravenous infusion of 15 mg/kg body weight in 6 adult subjects undergoing continuous ambulatory peritoneal dialysis. Concentrations of cefmenoxime in serum, urine and dialysate were determined by high-pressure liquid chromatography. The mean peak serum concentration was 92.8 +/- 11.6 micrograms/ml and the harmonic mean for the elimination half-life was 5.46 h. The volume of distribution at steady-state was 14.60 +/- 3.01 l/kg. Total body clearance of the drug was 31 +/- 7.7 ml/min with 8 +/- 5% and 5.75 +/- 2.72% of the administered dose being eliminated by renal and peritoneal clearance, respectively. Peritoneal clearance for all exchanges (n = 24) was 1.93 +/- 68 ml/min. These data suggest that peritoneal losses of this drug are minimal and doses conventionally employed in advanced renal failure can be utilized in the management of systemic infections.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3464435     DOI: 10.1007/BF00608221

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  16 in total

Review 1.  Microbiologic aspects of chronic ambulatory peritoneal dialysis.

Authors:  S I Vas
Journal:  Kidney Int       Date:  1983-01       Impact factor: 10.612

2.  Intramuscular and intravenous pharmacokinetics of cefmenoxime, a new broad-spectrum cephalosporin, in healthy subjects.

Authors:  G R Granneman; L T Sennello; F J Steinberg; R C Sonders
Journal:  Antimicrob Agents Chemother       Date:  1982-01       Impact factor: 5.191

3.  Effect of probenecid on the pharmacokinetics of cefmenoxime.

Authors:  L T Sennello; D Quinn; D E Rollins; K G Tolman; R C Sonders
Journal:  Antimicrob Agents Chemother       Date:  1983-06       Impact factor: 5.191

4.  High-performance liquid chromatographic determination of cefmenoxime (AB-50912) in human plasma and urine.

Authors:  I A Noonan; J G Gambertoglio; S L Barriere; J E Conte; E T Lin
Journal:  J Chromatogr       Date:  1983-04-08

5.  Unidirectional absorption of gentamicin from the peritoneum during continuous ambulatory peritoneal dialysis.

Authors:  P Somani; R S Shapiro; H Stockard; J T Higgins
Journal:  Clin Pharmacol Ther       Date:  1982-07       Impact factor: 6.875

6.  Cefmenoxime pharmacokinetics in healthy volunteers and subjects with renal insufficiency and on hemodialysis.

Authors:  J G Gambertoglio; D P Alexander; S L Barriere
Journal:  Antimicrob Agents Chemother       Date:  1984-12       Impact factor: 5.191

7.  Cefmenoxime pharmacokinetics in patients with renal insufficiency.

Authors:  R E Polk; D A Sica; T M Kerkering; B J Kline; P M Patterson; J W Baggett
Journal:  Antimicrob Agents Chemother       Date:  1984-09       Impact factor: 5.191

8.  Vancomycin disposition during continuous ambulatory peritoneal dialysis: a pharmacokinetic analysis of peritoneal drug transport.

Authors:  M C Rogge; C A Johnson; S W Zimmerman; P G Welling
Journal:  Antimicrob Agents Chemother       Date:  1985-04       Impact factor: 5.191

9.  Effect of protein binding on cefmenoxime steady-state kinetics in critical patients.

Authors:  D P Reitberg; T J Cumbo; I L Smith; J J Schentag
Journal:  Clin Pharmacol Ther       Date:  1984-01       Impact factor: 6.875

10.  Vancomycin pharmacokinetics in continuous ambulatory peritoneal dialysis patients with peritonitis.

Authors:  A M Harford; D A Sica; T Tartaglione; R E Polk; H P Dalton; W Poynor
Journal:  Nephron       Date:  1986       Impact factor: 2.847

View more
  2 in total

Review 1.  Cefmenoxime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  D M Campoli-Richards; P A Todd
Journal:  Drugs       Date:  1987-08       Impact factor: 9.546

Review 2.  FDA-Approved Oximes and Their Significance in Medicinal Chemistry.

Authors:  Jyothi Dhuguru; Eugene Zviagin; Rachid Skouta
Journal:  Pharmaceuticals (Basel)       Date:  2022-01-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.